查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1553673

人工重要器官和医疗仿生市场规模、份额、趋势分析报告：2024-2030 年人工器官、仿生学、地区和细分市场预测

Artificial Vital Organs And Medical Bionics Market Size, Share & Trends Analysis Report By Artificial Organs (Heart, Kidney, Liver), By Bionics (Ear Bionics, Vision Bionics, Exoskeletons), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

人工重要器官和医学仿生学市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，全球人工重要器官和医疗仿生市场规模将达到701亿美元，2024年至2030年复合年增长率为9.3%。

人工重要器官市场的主要成长动力包括越来越多的老年人口患有导致器官衰竭和损伤的心血管疾病和呼吸系统疾病等慢性疾病。

此外，由于先天因素、事故、兵役、工业事故等导致肢体和手臂缺陷等身体残疾的患者数量不断增加，可能会在预测期内积极推动医疗仿生市场的成长。

各国政府发起的全民健保计画的广泛采用以及公共和私人报销政策覆盖范围的扩大预计将推动未来七年人工重要器官和医疗仿生学的使用。

人造重要器官市场包括人工心臟、人造胰臟、人工肾臟和人造肺等产品。这些用于患有器官损伤或完全器官衰竭的患者的器官移植。

2014年，由于高血糖、高血压、术后感染疾病、肾丝球疾病、损伤和烧烫伤、爱滋病毒等危险因子的日益流行，人工肾臟市场占据了最大的市场占有率，超过60%。

人工肝预计在七年的预测期内将以有利的速度成长，是成长最快的产品领域。快速成长的关键因素包括慢性阻塞性肺病（COPD）等慢性肺部疾病的盛行率增加以及使用机械人工呼吸器的缺点。

医学仿生部分包括大脑、耳朵、视觉仿生、外骨骼和仿生肢体等产品。 2014年，由于患有神经系统疾病的患者不断增加，脑仿生占据了最大的市场占有率，约41%。此外，脊髓刺激设备、迷走神经刺激设备和深层脑部刺激器的非侵入性是未来七年对市场成长产生正面影响的主要因素。由于外骨骼的应用范围广泛，包括救援、紧急应变、家庭医疗保健和患者康復，对外骨骼的需求可能会激增。

人造重要器官和医疗仿生学市场报告亮点

  • 脑仿生在人工重要器官和医疗仿生市场中占据主导地位，2023 年收益占有率为 34.9%。帕金森氏症、忧郁症和癫痫等神经系统疾病的盛行率不断上升正在推动市场成长。
  • 2023年销售份额为57.3%，心臟领域占市场主导地位。这种增长是由于慢性病盛行率的增加、用于移植的心臟的短缺以及外科手术和更强大、更有效的药物和治疗方法的进步。
  • 北美人工重要器官和医疗仿生市场主导全球人工重要器官和医疗仿生市场，2023年销售份额为44.6%。
  • 亚太地区人造重要器官和医疗仿生学市场预计在预测期内成长最快，复合年增长率为 11.1%。由于可支配收入的增加、医疗保健基础设施的改善和意识的提高，市场将在预测期内呈现成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章：人工重要器官和医疗仿生市场的变数、趋势和范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 人工重要器官与医学仿生市场分析工具
    • 波特的分析
    • PESTEL分析

第四章人工重要器官及医学仿生市场：人工重要器官预估及趋势分析

  • 细分仪表板
  • 心
  • 肾
  • 肝
  • 胰臟
  • 肺

第五章人工重要器官与医学仿生市场：仿生学估计与趋势分析

  • 细分仪表板
  • 人工重要器官与医疗仿生市场：仿生学波动分析，2023 年及 2030 年
  • 耳仿生学
  • 外骨骼
  • 仿生肢体
  • 脑仿生学
  • 心臟仿生学

第六章人工重要器官与医学仿生市场：区域估计与趋势分析

  • 2023年和2030年按地区分類的人工重要器官和医疗仿生市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Medtronic, Inc.
    • LifeNet Health
    • Terumo Corporation
    • Ekso Bionics Holdings, Inc.
    • Nano Retina Ltd.
    • Edwards Lifesciences Corporation
    • InnoScot Health Ltd.
    • Ottobock SE &Co. KGaA
    • Orthofix Medical Inc.
简介目录
Product Code: 978-1-68038-546-5

Artificial Vital Organs And Medical Bionics Market Growth & Trends:

The global artificial vital organs and medical bionics market size is expected to reach USD 70.1 billion by 2030, registering a CAGR of 9.3% from 2024 to 2030, according to a new report by Grand View Research, Inc. Key growth drivers identified in the artificial vital organs market include increasing base of geriatric population suffering from chronic diseases such as cardiovascular and respiratory diseases leading to organ failures or damage.

Furthermore, the increasing number of patients suffering from physical disabilities such as loss of limbs and arms owing to congenital factors, accidents, serving in armed forces and industrial accidents is likely to positively reinforce medical bionics market growth over the forecast period.

The proliferation of universal health coverage schemes launched by various governments and increasing public and private reimbursement policy coverage are major trends expected to boost the usage rates of artificial vital organs and medical bionics in the next seven years.

The artificial vital organs market includes products such as artificial heart, pancreas, kidneys, and lungs. These are used for organ transplantation in patients suffering with organ damages or complete organ failures.

In 2014, artificial kidney market accounted for the largest market share of over 60% owing to increasing prevalence of high blood sugar, hypertension, post-surgery infections, glomerular diseases, injury or burns, HIV, and other risk factors.

Artificial liver is expected to be the fastest growing product segment growing at a lucrative rate over the forecast period of seven years. Key factors attributing to its rapid growth include increasing prevalence of chronic lung diseases such as COPD and disadvantages of using mechanical ventilators.

The medical bionics segment includes products such as brain, ear, vision bionics, exoskeleton, and bionic limbs. In 2014, brain bionics held the largest market share of nearly 41% due to the continually increasing number of patients suffering from neurological conditions. Furthermore, non-invasive nature of spinal cord stimulators, vagus nerve stimulators, and deep brain stimulators are key factors positively impacting market growth in the next seven years. Exoskeletons are likely to witness a rapid rise in demand owing to its wide applications in rescue, emergency response, home healthcare, and patient rehabilitation.

Artificial Vital Organs And Medical Bionics Market Report Highlights:

  • Brain bionics dominated the artificial vital organs and medical bionics market with a revenue share of 34.9% in 2023. Increased prevalence of neurological conditions such as Parkinson's disease, depression, and epilepsy are driving market growth.
  • The heart segment dominated the market with a revenue share of 57.3% in 2023. This increase is happening due to an increase in the incidence of chronic diseases, scarcity of hearts for transplant, and advancement of the operations and potent effective drugs and treatment.
  • North America artificial vital organs and medical bionics market dominated the global artificial vital organs and medical bionics market with a revenue share of 44.6% in 2023.
  • Asia Pacific artificial vital organs and medical bionics market is expected to the fastest growth in the forecast period with a CAGR of 11.1%. Due to rising disposable income, elevated healthcare infrastructure, and awareness the marketplace is displaying growth within the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Artificial Vital Organs and Medical Bionics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Artificial Vital Organs and Medical Bionics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Artificial Vital Organs and Medical Bionics Market: Artificial Organ Estimates & Trend Analysis

  • 4.1. Segment Dashboard
    • 4.1.1. Artificial Vital Organs and Medical Bionics Market: Artificial Organ Movement Analysis, 2023 & 2030 (USD Million)
  • 4.2. Heart
    • 4.2.1. Heart Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Kidney
    • 4.3.1. Kidney Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Liver
    • 4.4.1. Liver Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Pancreas
    • 4.5.1. Pancreas Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Lungs
    • 4.6.1. Lungs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Artificial Vital Organs and Medical Bionics Market: Bionics Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Artificial Vital Organs and Medical Bionics Market: Bionics Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Ear Bionics
    • 5.3.1. Ear Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Vision Bionics
    • 5.3.3. Vision Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Exoskeletons
    • 5.4.1. Exoskeletons Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Bionic Limbs
    • 5.5.1. Bionic Limbs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Brain bionics
    • 5.6.1. Brain Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Cardiac Bionics
    • 5.7.1. Cardiac Bionics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Artificial Vital Organs and Medical Bionics Market: Regional Estimates & Trend Analysis

  • 6.1. Artificial Vital Organs and Medical Bionics Market Share, By Region, 2023 & 2030 (USD Billion)
  • 6.2. North America
    • 6.2.1. North America Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Artificial Vital Organs and Medical Bionics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Medtronic, Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. LifeNet Health
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. Terumo Corporation
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. Ekso Bionics Holdings, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Nano Retina Ltd.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. Edwards Lifesciences Corporation
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. InnoScot Health Ltd.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Ottobock SE & Co. KGaA
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Orthofix Medical Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives